[Symptomatic therapy refractory myocardial ischemia in coronary heart disease. Chronic intermittent urokinase therapy and invasive therapeutic measures].
Leschke
M
M
Klinik für Kardiologie, Pneumologie und Angiologie der Heinrich-Heine-Universität Düsseldorf.
Schoebel
F C
FC
Strauer
B E
BE
D000328:Adult; D000368:Aged; D015906:Angioplasty, Balloon, Coronary; D002986:Clinical Trials as Topic; D003131:Combined Modality Therapy; D003327:Coronary Disease / Q000188:drug therapy* / Q000401:mortality; D003328:Coronary Thrombosis / Q000188:drug therapy* / Q000401:mortality; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D005260:Female; D005343:Fibrinolytic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D015996:Survival Rate; D015912:Thrombolytic Therapy; D016896:Treatment Outcome
D005343:Fibrinolytic Agents
Symptomatische therapierefraktäre Myokardischämie bei koronarer Herzkrankheit. Chronisch-intermittierende Urokinasetherapie und invasive Therapieverfahren.